BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Banerjee MN, Bolli R, Hare JM. Clinical Studies of Cell Therapy in Cardiovascular Medicine: Recent Developments and Future Directions. Circ Res 2018;123:266-87. [PMID: 29976692 DOI: 10.1161/CIRCRESAHA.118.311217] [Cited by in Crossref: 71] [Cited by in F6Publishing: 43] [Article Influence: 23.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhang F, Hu G, Chen X, Zhang L, Guo L, Li C, Zhao H, Cui Z, Guo X, Sun F, Song D, Yan W, Xia Y, Wang S, Fan M, Tao L. Excessive branched-chain amino acid accumulation restricts mesenchymal stem cell-based therapy efficacy in myocardial infarction. Signal Transduct Target Ther 2022;7:171. [PMID: 35654769 DOI: 10.1038/s41392-022-00971-7] [Reference Citation Analysis]
2 Kang Y, Nasr M, Guo Y, Uchida S, Weirick T, Li H, Kim J, Moore JB 4th, Muthusamy S, Bolli R, Wysoczynski M. Administration of cardiac mesenchymal cells modulates innate immunity in the acute phase of myocardial infarction in mice. Sci Rep 2020;10:14754. [PMID: 32901075 DOI: 10.1038/s41598-020-71580-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Liu M, López de Juan Abad B, Cheng K. Cardiac fibrosis: Myofibroblast-mediated pathological regulation and drug delivery strategies. Adv Drug Deliv Rev 2021;173:504-19. [PMID: 33831476 DOI: 10.1016/j.addr.2021.03.021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
4 Nguyen AH, Marsh P, Schmiess-Heine L, Burke PJ, Lee A, Lee J, Cao H. Cardiac tissue engineering: state-of-the-art methods and outlook. J Biol Eng 2019;13:57. [PMID: 31297148 DOI: 10.1186/s13036-019-0185-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 9.0] [Reference Citation Analysis]
5 Bolli RAR, Arshia A, Hassan SA, Dasari C, Nong Y, Guo Y, Tomlin AA, Li Q. Cardiac Mesenchymal Cells Cultured at Physiologic Oxygen Tension Have Superior Therapeutic Efficacy in Heart Failure Caused by Myocardial Infarction. Front Cell Dev Biol 2021;9:662415. [PMID: 34124043 DOI: 10.3389/fcell.2021.662415] [Reference Citation Analysis]
6 Turner D, Rieger AC, Balkan W, Hare JM. Clinical-based Cell Therapies for Heart Disease-Current and Future State. Rambam Maimonides Med J. 2020;11. [PMID: 32374254 DOI: 10.5041/rmmj.10401] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Ma S, Yan J, Chen L, Zhu Y, Chen K, Zheng C, Shen M, Liao Y. A Bibliometric and Visualized Analysis of Cardiac Regeneration Over a 20-Year Period. Front Cardiovasc Med 2021;8:789503. [PMID: 34966800 DOI: 10.3389/fcvm.2021.789503] [Reference Citation Analysis]
8 Constantinou C, Miranda AMA, Chaves P, Bellahcene M, Massaia A, Cheng K, Samari S, Rothery SM, Chandler AM, Schwarz RP, Harding SE, Punjabi P, Schneider MD, Noseda M. Human pluripotent stem cell-derived cardiomyocytes as a target platform for paracrine protection by cardiac mesenchymal stromal cells. Sci Rep 2020;10:13016. [PMID: 32747668 DOI: 10.1038/s41598-020-69495-w] [Reference Citation Analysis]
9 Chimenti I, Picchio V, Pagano F, Schirone L, Schiavon S, D'Ambrosio L, Valenti V, Forte M, di Nonno F, Rubattu S, Peruzzi M, Versaci F, Greco E, Calogero A, De Falco E, Frati G, Sciarretta S. The impact of autophagy modulation on phenotype and survival of cardiac stromal cells under metabolic stress. Cell Death Discov 2022;8:149. [PMID: 35365624 DOI: 10.1038/s41420-022-00924-7] [Reference Citation Analysis]
10 Hare JM, Yang P. Regenerating Endothelium and Restoring Microvascular Endothelial Function. JACC Cardiovasc Imaging 2022;15:825-7. [PMID: 35512955 DOI: 10.1016/j.jcmg.2022.02.014] [Reference Citation Analysis]
11 Bolli R, Mitrani RD, Hare JM, Pepine CJ, Perin EC, Willerson JT, Traverse JH, Henry TD, Yang PC, Murphy MP, March KL, Schulman IH, Ikram S, Lee DP, O'Brien C, Lima JA, Ostovaneh MR, Ambale-Venkatesh B, Lewis G, Khan A, Bacallao K, Valasaki K, Longsomboon B, Gee AP, Richman S, Taylor DA, Lai D, Sayre SL, Bettencourt J, Vojvodic RW, Cohen ML, Simpson L, Aguilar D, Loghin C, Moyé L, Ebert RF, Davis BR, Simari RD; Cardiovascular Cell Therapy Research Network (CCTRN). A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trial. Eur J Heart Fail 2021;23:661-74. [PMID: 33811444 DOI: 10.1002/ejhf.2178] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
12 van den Hoogen P, de Jager SCA, Mol EA, Schoneveld AS, Huibers MMH, Vink A, Doevendans PA, Laman JD, Sluijter JPG. Potential of mesenchymal- and cardiac progenitor cells for therapeutic targeting of B-cells and antibody responses in end-stage heart failure. PLoS One 2019;14:e0227283. [PMID: 31891633 DOI: 10.1371/journal.pone.0227283] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
13 Sava RI, Pepine CJ, March KL. Immune Dysregulation in HFpEF: A Target for Mesenchymal Stem/Stromal Cell Therapy. J Clin Med 2020;9:E241. [PMID: 31963368 DOI: 10.3390/jcm9010241] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
14 Graber M, Nägele F, Hirsch J, Pölzl L, Schweiger V, Lechner S, Grimm M, Cooke JP, Gollmann-tepeköylü C, Holfeld J. Cardiac Shockwave Therapy – A Novel Therapy for Ischemic Cardiomyopathy? Front Cardiovasc Med 2022;9:875965. [DOI: 10.3389/fcvm.2022.875965] [Reference Citation Analysis]
15 Kharbikar BN, Mohindra P, Desai TA. Biomaterials to enhance stem cell transplantation. Cell Stem Cell 2022;29:692-721. [PMID: 35483364 DOI: 10.1016/j.stem.2022.04.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 O'Brien CG, Ozen MO, Ikeda G, Vaskova E, Jung JH, Bayardo N, Santoso MR, Shi L, Wahlquist C, Jiang Z, Jung Y, Zeng Y, Egan E, Sinclair R, Gee A, Witteles R, Mercola M, Svensson KJ, Demirci U, Yang PC. Mitochondria-Rich Extracellular Vesicles Rescue Patient-Specific Cardiomyocytes From Doxorubicin Injury: Insights Into the SENECA Trial. JACC CardioOncol 2021;3:428-40. [PMID: 34604804 DOI: 10.1016/j.jaccao.2021.05.006] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Fine B, Vunjak-Novakovic G. Heart regeneration in mouse and human: A bioengineering perspective. Curr Opin Physiol 2020;14:56-63. [PMID: 32095673 DOI: 10.1016/j.cophys.2020.01.004] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Yamada S, Jeon R, Garmany A, Behfar A, Terzic A. Screening for regenerative therapy responders in heart failure. Biomark Med 2021;15:775-83. [PMID: 34169733 DOI: 10.2217/bmm-2020-0683] [Reference Citation Analysis]
19 Li M, Yamada S, Shi A, Singh RD, Rolland TJ, Jeon R, Lopez N, Shelerud L, Terzic A, Behfar A. Brachyury engineers cardiac repair competent stem cells. Stem Cells Transl Med 2021;10:385-97. [PMID: 33098750 DOI: 10.1002/sctm.20-0193] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
20 He L, Nguyen NB, Ardehali R, Zhou B. Heart Regeneration by Endogenous Stem Cells and Cardiomyocyte Proliferation: Controversy, Fallacy, and Progress.Circulation. 2020;142:275-291. [PMID: 32687441 DOI: 10.1161/CIRCULATIONAHA.119.045566] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
21 Nose N, Nogami S, Koshino K, Chen X, Werner RA, Kashima S, Rowe SP, Lapa C, Fukuchi K, Higuchi T. [18F]FDG-labelled stem cell PET imaging in different route of administrations and multiple animal species. Sci Rep 2021;11:10896. [PMID: 34035416 DOI: 10.1038/s41598-021-90383-4] [Reference Citation Analysis]
22 Zhu D, Li Z, Huang K, Caranasos TG, Rossi JS, Cheng K. Minimally invasive delivery of therapeutic agents by hydrogel injection into the pericardial cavity for cardiac repair. Nat Commun 2021;12:1412. [PMID: 33658506 DOI: 10.1038/s41467-021-21682-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 12.0] [Reference Citation Analysis]
23 Grigorian Shamagian L, Madonna R, Taylor D, Climent AM, Prosper F, Bras-Rosario L, Bayes-Genis A, Ferdinandy P, Fernández-Avilés F, Izpisua Belmonte JC, Fuster V, Bolli R. Perspectives on Directions and Priorities for Future Preclinical Studies in Regenerative Medicine. Circ Res 2019;124:938-51. [PMID: 30870121 DOI: 10.1161/CIRCRESAHA.118.313795] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 6.3] [Reference Citation Analysis]
24 Tomov ML, Gil CJ, Cetnar A, Theus AS, Lima BJ, Nish JE, Bauser-Heaton HD, Serpooshan V. Engineering Functional Cardiac Tissues for Regenerative Medicine Applications. Curr Cardiol Rep 2019;21:105. [PMID: 31367922 DOI: 10.1007/s11886-019-1178-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
25 Cruz-Samperio R, Jordan M, Perriman A. Cell augmentation strategies for cardiac stem cell therapies. Stem Cells Transl Med 2021;10:855-66. [PMID: 33660953 DOI: 10.1002/sctm.20-0489] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Montero P, Flandes-Iparraguirre M, Musquiz S, Pérez Araluce M, Plano D, Sanmartín C, Orive G, Gavira JJ, Prosper F, Mazo MM. Cells, Materials, and Fabrication Processes for Cardiac Tissue Engineering. Front Bioeng Biotechnol 2020;8:955. [PMID: 32850768 DOI: 10.3389/fbioe.2020.00955] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
27 Yamada S, Arrell DK, Rosenow CS, Bartunek J, Behfar A, Terzic A. Ventricular remodeling in ischemic heart failure stratifies responders to stem cell therapy. Stem Cells Transl Med 2020;9:74-9. [PMID: 31373782 DOI: 10.1002/sctm.19-0149] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
28 Pattar SS, Fatehi Hassanabad A, Fedak PWM. Application of Bioengineered Materials in the Surgical Management of Heart Failure. Front Cardiovasc Med 2019;6:123. [PMID: 31482096 DOI: 10.3389/fcvm.2019.00123] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
29 Brody M, Agronin M, Herskowitz BJ, Bookheimer SY, Small GW, Hitchinson B, Ramdas K, Wishard T, McInerney KF, Vellas B, Sierra F, Jiang Z, Mcclain-Moss L, Perez C, Fuquay A, Rodriguez S, Hare JM, Oliva AA Jr, Baumel B. Results and insights from a phase I clinical trial of Lomecel-B for Alzheimer's disease. Alzheimers Dement 2022. [PMID: 35357079 DOI: 10.1002/alz.12651] [Reference Citation Analysis]
30 Bolli R, Perin EC, Willerson JT, Yang PC, Traverse JH, Henry TD, Pepine CJ, Mitrani RD, Hare JM, Murphy MP, March KL, Ikram S, Lee DP, O'Brien C, Durand JB, Miller K, Lima JA, Ostovaneh MR, Ambale-Venkatesh B, Gee AP, Richman S, Taylor DA, Sayre SL, Bettencourt J, Vojvodic RW, Cohen ML, Simpson LM, Lai D, Aguilar D, Loghin C, Moyé L, Ebert RF, Davis BR, Simari RD; Cardiovascular Cell Therapy Research Network (CCTRN). Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients: The CCTRN SENECA Trial. JACC CardioOncol 2020;2:581-95. [PMID: 33403362 DOI: 10.1016/j.jaccao.2020.09.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
31 Kato M, Tsunekawa S, Nakamura N, Miura-Yura E, Yamada Y, Hayashi Y, Nakai-Shimoda H, Asano S, Hayami T, Motegi M, Asano-Hayami E, Sasajima S, Morishita Y, Himeno T, Kondo M, Kato Y, Izumoto-Akita T, Yamamoto A, Naruse K, Nakamura J, Kamiya H. Secreted Factors from Stem Cells of Human Exfoliated Deciduous Teeth Directly Activate Endothelial Cells to Promote All Processes of Angiogenesis. Cells 2020;9:E2385. [PMID: 33142678 DOI: 10.3390/cells9112385] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
32 Wysoczynski M, Pathan A, Moore JB 4th, Farid T, Kim J, Nasr M, Kang Y, Li H, Bolli R. Pro-Angiogenic Actions of CMC-Derived Extracellular Vesicles Rely on Selective Packaging of Angiopoietin 1 and 2, but Not FGF-2 and VEGF. Stem Cell Rev Rep 2019;15:530-42. [PMID: 31102187 DOI: 10.1007/s12015-019-09891-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
33 Mamazhakypov A, Sommer N, Assmus B, Tello K, Schermuly RT, Kosanovic D, Sarybaev AS, Weissmann N, Pak O. Novel Therapeutic Targets for the Treatment of Right Ventricular Remodeling: Insights from the Pulmonary Artery Banding Model. Int J Environ Res Public Health 2021;18:8297. [PMID: 34444046 DOI: 10.3390/ijerph18168297] [Reference Citation Analysis]
34 Wysoczynski M, Bolli R. A realistic appraisal of the use of embryonic stem cell-based therapies for cardiac repair. Eur Heart J 2020;41:2397-404. [PMID: 31778154 DOI: 10.1093/eurheartj/ehz787] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
35 Murphy JF, Mayourian J, Stillitano F, Munawar S, Broughton KM, Agullo-Pascual E, Sussman MA, Hajjar RJ, Costa KD, Turnbull IC. Adult human cardiac stem cell supplementation effectively increases contractile function and maturation in human engineered cardiac tissues. Stem Cell Res Ther 2019;10:373. [PMID: 31801634 DOI: 10.1186/s13287-019-1486-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
36 Toong DWY, Toh HW, Ng JCK, Wong PEH, Leo HL, Venkatraman S, Tan LP, Ang HY, Huang Y. Bioresorbable Polymeric Scaffold in Cardiovascular Applications. Int J Mol Sci 2020;21:E3444. [PMID: 32414114 DOI: 10.3390/ijms21103444] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
37 Ghanta RK, Aghlara-Fotovat S, Pugazenthi A, Ryan CT, Singh VP, Mathison M, Jarvis MI, Mukherjee S, Hernandez A, Veiseh O. Immune-modulatory alginate protects mesenchymal stem cells for sustained delivery of reparative factors to ischemic myocardium. Biomater Sci 2020;8:5061-70. [PMID: 32797143 DOI: 10.1039/d0bm00855a] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
38 Zhang J, Bolli R, Garry DJ, Marbán E, Menasché P, Zimmermann WH, Kamp TJ, Wu JC, Dzau VJ. Basic and Translational Research in Cardiac Repair and Regeneration: JACC State-of-the-Art Review. J Am Coll Cardiol 2021;78:2092-105. [PMID: 34794691 DOI: 10.1016/j.jacc.2021.09.019] [Reference Citation Analysis]
39 Rowe G, Kelm NQ, Beare JE, Tracy E, Yuan F, LeBlanc AJ. Enhanced beta-1 adrenergic receptor responsiveness in coronary arterioles following intravenous stromal vascular fraction therapy in aged rats. Aging (Albany NY) 2019;11:4561-78. [PMID: 31296794 DOI: 10.18632/aging.102069] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
40 Cassani M, Fernandes S, Vrbsky J, Ergir E, Cavalieri F, Forte G. Combining Nanomaterials and Developmental Pathways to Design New Treatments for Cardiac Regeneration: The Pulsing Heart of Advanced Therapies. Front Bioeng Biotechnol 2020;8:323. [PMID: 32391340 DOI: 10.3389/fbioe.2020.00323] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
41 Bashor CJ, Hilton IB, Bandukwala H, Smith DM, Veiseh O. Engineering the next generation of cell-based therapeutics. Nat Rev Drug Discov. [DOI: 10.1038/s41573-022-00476-6] [Reference Citation Analysis]
42 Yamada S, Bartunek J, Behfar A, Terzic A. Mass Customized Outlook for Regenerative Heart Failure Care. Int J Mol Sci 2021;22:11394. [PMID: 34768825 DOI: 10.3390/ijms222111394] [Reference Citation Analysis]
43 Han X, Li L, Xie T, Chen S, Zou Y, Jin X, Li S, Wang M, Han N, Fan G, Liu W, Wang W. “Ferrero-like” nanoparticles knotted injectable hydrogels to initially scavenge ROS and lastingly promote vascularization in infarcted hearts. Sci China Technol Sci 2020;63:2435-48. [DOI: 10.1007/s11431-020-1638-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
44 Cheng H, Chang S, Xu R, Chen L, Song X, Wu J, Qian J, Zou Y, Ma J. Hypoxia-challenged MSC-derived exosomes deliver miR-210 to attenuate post-infarction cardiac apoptosis. Stem Cell Res Ther 2020;11:224. [PMID: 32513270 DOI: 10.1186/s13287-020-01737-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
45 Barreto S, Hamel L, Schiatti T, Yang Y, George V. Cardiac Progenitor Cells from Stem Cells: Learning from Genetics and Biomaterials. Cells 2019;8:E1536. [PMID: 31795206 DOI: 10.3390/cells8121536] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
46 Liu Y, Niu R, Li W, Lin J, Stamm C, Steinhoff G, Ma N. Therapeutic potential of menstrual blood-derived endometrial stem cells in cardiac diseases. Cell Mol Life Sci. 2019;76:1681-1695. [PMID: 30721319 DOI: 10.1007/s00018-019-03019-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
47 LeBlanc AJ, Uchida S. A step closer to improving cardiac homing of adipose-derived mesenchymal stem cells. Am J Physiol Heart Circ Physiol 2019;316:H260-1. [PMID: 30461301 DOI: 10.1152/ajpheart.00736.2018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
48 Das S, Nam H, Jang J. 3D bioprinting of stem cell-laden cardiac patch: A promising alternative for myocardial repair. APL Bioeng 2021;5:031508. [PMID: 34368602 DOI: 10.1063/5.0030353] [Reference Citation Analysis]
49 Sundin A, Balkan W, Hare JM. Can't Patch Everything: Personalized Medicine for Cell Therapy in Dilated Cardiomyopathy. J Am Heart Assoc 2021;10:e021867. [PMID: 34212767 DOI: 10.1161/JAHA.121.021867] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
50 Sant'Anna RT, Eibel B, Markoski MM, Rodrigues CG, de Salles FB, Giusti II, Nesralla IA, Nardi NB, Kalil RAK. Gene therapy for refractory angina and cell therapy for heart failure: experience of a Brazilian research group. Gene Ther 2020;27:40-50. [PMID: 31278371 DOI: 10.1038/s41434-019-0087-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
51 Biressi S, Filareto A, Rando TA. Stem cell therapy for muscular dystrophies. J Clin Invest 2020;130:5652-64. [PMID: 32946430 DOI: 10.1172/JCI142031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
52 Ibarra-Ibarra BR, Franco M, Paez A, López EV, Massó F. Improved Efficiency of Cardiomyocyte-Like Cell Differentiation from Rat Adipose Tissue-Derived Mesenchymal Stem Cells with a Directed Differentiation Protocol. Stem Cells Int 2019;2019:8940365. [PMID: 31065283 DOI: 10.1155/2019/8940365] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
53 Morrissey J, Mesquita FCP, Chacon-alberty L, Hochman-mendez C. Mining the Mesenchymal Stromal Cell Secretome in Patients with Chronic Left Ventricular Dysfunction. Cells 2022;11:2092. [DOI: 10.3390/cells11132092] [Reference Citation Analysis]
54 Guduric-Fuchs J, Pedrini E, Lechner J, Chambers SEJ, O'Neill CL, Mendes Lopes de Melo J, Pathak V, Church RH, McKeown S, Bojdo J, Mcloughlin KJ, Stitt AW, Medina RJ. miR-130a activates the VEGFR2/STAT3/HIF1α axis to potentiate the vasoregenerative capacity of endothelial colony-forming cells in hypoxia. Mol Ther Nucleic Acids 2021;23:968-81. [PMID: 33614244 DOI: 10.1016/j.omtn.2021.01.015] [Reference Citation Analysis]
55 Hare JM, Beerman I. Regenerative Medicine and the Biology of Aging. J Gerontol A Biol Sci Med Sci 2019;74:1339-40. [PMID: 31125054 DOI: 10.1093/gerona/glz132] [Reference Citation Analysis]
56 Duffy GP, Robinson ST, O'Connor R, Wylie R, Mauerhofer C, Bellavia G, Straino S, Cianfarani F, Mendez K, Beatty R, Levey R, O'Sullivan J, McDonough L, Kelly H, Roche ET, Dolan EB. Implantable Therapeutic Reservoir Systems for Diverse Clinical Applications in Large Animal Models. Adv Healthc Mater 2020;9:e2000305. [PMID: 32339411 DOI: 10.1002/adhm.202000305] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]